Special Notice: LDN's First US Clinical Trial Needs Your Help.

[Guest guest]

Special Notice: LDN's First US Clinical Trial Needs Your Help

As announced in our Latest News for November 2003, Jill P. , MD,

Professor of Medicine at Penn State's Hershey Medical Center, is

currently enrolling patients in an 8-week pilot study. This will test

the effectiveness of a low dose of naltrexone in offering relief to

patients suffering from symptoms of Crohn's Disease and, if

successful, should lead to a full-fledged clinical trial. As of early

February 2004, the study had been able to enlist only 10 volunteers

with Crohn's disease to participate. This despite the fact that those

few who have so far signed up are very enthusiastic about the relief

they are experiencing from the LDN.

Here is the chance that members of the LDN- group have been

waiting for: to help LDN achieve medical verification and legitimacy

through a university-sponsored scientific clinical trial. If you know

anyone on the East Coast of the United States who has Crohn's disease,

please ask them to consider participating in this study being held by

the Hershey Medical Center of Pennsylvania State University. Cost of

medication, office visits, and blood work are paid by the study.

The study is described at this website address:

http://www.hmc.psu.edu/colorectal/research/naltrexone.htm.

Those interested should contact Bingaman, R.N. at

717-531-8108.

LDN Website Editors

email@...

[Guest guest]

Sorry,

I don’t have Crohn’s Disease.

Thanks,

Helen

-----Original Message-----

From: Gluck

[mailto:joelg@...]

Sent: Sunday, February 15, 2004

2:43 AM

To:

low dose naltrexone

Subject: [low dose naltrexone]

Special Notice: LDN's First US Clinical Trial Needs Your Help.

Special Notice: LDN's

First US Clinical Trial Needs Your Help

As announced in our Latest News for

November 2003, Jill P. , MD,

Professor of Medicine at Penn State's

Hershey Medical Center, is

currently enrolling patients in an 8-week

pilot study. This will test

the effectiveness of a low dose of

naltrexone in offering relief to

patients suffering from symptoms of Crohn's

Disease and, if

successful, should lead to a full-fledged

clinical trial. As of early

February 2004, the study had been able to

enlist only 10 volunteers

with Crohn's disease to participate. This

despite the fact that those

few who have so far signed up are very

enthusiastic about the relief

they are experiencing from the LDN.

Here is the chance that members of the

LDN- group have been

waiting for: to help LDN achieve medical

verification and legitimacy

through a university-sponsored scientific

clinical trial. If you know

anyone on the East Coast of the United

States who has Crohn's disease,

please ask them to consider participating

in this study being held by

the Hershey Medical Center of Pennsylvania

State University. Cost of

medication, office visits, and blood work

are paid by the study.

The study is described at this website

address:

http://www.hmc.psu.edu/colorectal/research/naltrexone.htm.

Those interested should contact

Bingaman, R.N. at

717-531-8108.

LDN Website Editors

email@...